Testing arbidol for allergic rhinitis
Part of Ear, nose & throat, Immune system & allergy, Lungs & breathing clinical trials.
This trial tests if arbidol, an antiviral medicine, can safely treat allergic rhinitis (hay fever). It might help if your nasal symptoms like sneezing or stuffiness are moderate to severe.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have been diagnosed with allergic rhinitis (hay fever).
- You have at least 2 nasal symptoms like sneezing or runny nose, and they are moderate or worse.
- You are not pregnant, breastfeeding, or planning pregnancy during the study.
- You haven't been in another clinical trial in the last 3 months.
- You are willing to follow the study rules and sign a consent form.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study compares two common treatments for moderate to severe allergic rhinitis: using a nasal steroid spray plus a nasal antihistamine spray versus the same spray plus an oral antihistamine pill. It aims to find which combination works best to relieve symptoms like sneezing, stuffiness, and runny nose.
This study tests if acupuncture on a nerve in the head (sphenopalatine ganglion) can help reduce symptoms of allergic rhinitis (hay fever) like sneezing and runny nose.
This study tests whether taking a combination of probiotics (good bacteria) and vitamin D can help reduce hay fever symptoms. It may be a good option if your vitamin D is low and you haven't used probiotics recently.
This Phase 2 study tests a “viral” treatment meant to reprogram the lining of your nose to reduce allergy-like immune responses. It is testing whether this approach is safe and can help people with cat allergy (with or without asthma) or compare against healthy people.
This trial tests an experimental antibody (IL4Rα monoclonal antibody) for people with seasonal allergic rhinitis (hay fever) that is not well controlled by standard treatments like nasal steroid sprays. The goal is to see if this new treatment can help reduce allergy symptoms during pollen season.
This trial tests a new injection called GR1802 for people with seasonal allergic rhinitis (hay fever) that isn't well controlled by standard treatments. It aims to see if this medicine can help reduce symptoms during pollen season.
Hear when a new Allergic Rhinitis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.